XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
News
Current issue
Archival Issues
Search
Newsletter
Manuscript Submission
 » 
Journal Abstract
 
Non-alcoholic steatohepatitis (NASH) – pathogenesis, diagnosis, treatment
Danuta Dudzik, Małgorzata Knaś, Małgorzata Borzym-Kluczyk, Oxana Lukivskay’a, Vyacheslav Buko, Ewa Dudkiewicz, Katarzyna Knaś-Karaszewska, Sławomir Szajda, Joanna Jakimowicz-Rudy, Sylwia Chojnowska, Katarzyna Niediołko-Bagniuk, Krzysztof Zwierz
Medical Science Review - Hepatologia 2008; 8 48-58
aaICID: 862337
Article type: Review article
IC™ Value: 3.01
Abstract provided by Publisher
 
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are metabolic liver disorders of increasing importance. There are frequently associated with obesity, diabetes mellitus, hyperlipidemia and insulin resistance. NAFLD can progress to NASH, and NASH to cirhosis, liver failure, and hepatocellular carcinoma. Many drugs have been tried in treatment of NASH. The insulin sensitizing medicines as metformin, thiazolidinediones, antioxidant treatment, have shown promising results. Unfortunately, there is lack of controlled trials of growing numbers of anti-NASH drugs.

ICID 862337
 
FULL TEXT 195 KB


Related articles
  • in IndexCopernicus™
         liver disorders [1 related records]
         NASH [14 related records]
         Liver [1594 related records]


  •  

    Copyright © Medical Science Review - Hepatologia  2017
    Page created by Index Copernicus Ltd. All Rights reserved.